Major efforts have been devoted to the development of environments mimicking the natural composition and structure of tissues with special focus on nerve tissue and on directing neuronal outgrowth throughout recovery. However, these methods, including bio-mimetic scaffolds, nano-fibrous constructs and gels or gel filled tube, are suitable only for prefabricated implants.
We use a novel approach of injectable biomaterials, to be incorporated directly into the injured site.
The Commercial Benefit
Our cutting-edge platform:
• can be injected directly to the injured site without the need of full operation,
• promotes and directs neuronal growth for efficient regeneration,
• replaces the commonly used method of nerve allografts that damage the patient neurons,
• serves for controlled drug delivery,
• useful for the recovery of tissues,
• is not limited just to the nervous system.
The global nerve repair and regeneration market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%. The demand for neurological disorder devices and therapies is expected to exhibit an upsurge due to the rising awareness, the increasing incidence rate, the favorable government funding and reimbursement policies, and the continual technological advances offered by the key players of the industry. Furthermore, the emerging applications and therapies in treating the growing CNS disorders, such as Parkinson’s disease and Alzheimer’s, are further expected to drive the market growth.
• Nerve repair and regeneration market.
Team: Primary Inventor
Prof. Orit Shefi
Prof. Orit Shefi is a member of the Nano Medicine Center at the Institute of Nanotechnology and Advanced Materials (BINA), and an Associate Professor in the Faculty of Engineering.
Shefi has developed novel technologies for gene and drug delivery to study neurodegenerative diseases, and neuronal and skin regeneration.
PROF. Shefi's research has the potential to provide important new insights that may help to enhance neuronal recovery post trauma.
Future Research PLEASE ADD
We are looking for investors that are willing to support the research and commercialize this novel invention.